Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiepileptic Drugs: Sodium Channel Blockers
Local Anesthetics: Adverse Effects
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 16, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Toby Pillinger1, Atheeshaan Arumuhan2, Robert A McCutcheon3
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK; TUNE-UP Service, South London and Maudsley NHS Foundation Trust, Maudsley Hospital, Denmark Hill, London, UK; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
No abstract available in PubMed .